Answers are grounded in this paper and cite their sources.
Background: Considering the global SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) outbreak, comorbid conditions in children may enhance the risk of COVID-19-related severe morbidity and mortality with failure of chronic disease management.Objectives: To explore the various clinical, laboratory, and radiological presentations of COVID-19 among pediatric patients having chronic diseases and correlate the data with the outcomes of the included patients.Patients and Methods: This study was a descriptive study that was carried out on 36 pediatric patients with COVID-19 who have chronic diseases (16 cardiac patients, 8 neurological patients, 6 renal patients, 4 patients with genetic disorders, and 2 rheumatological patients) attending Pediatrics Department at Qena University Hospital. Clinical, laboratory, and radiological assessments of the included patients were performed. Serum angiotensin converting enzyme-2 (ACE-2) and tumor necrosis factor-alpha (TNF-α) were measured using commercially available ELISA kits.Results: Our study was conducted on 36 children, 22.22% of the studied cases were confirmed to have COVID-19, and 77.78% of cases were suspected. Regarding disease severity, 11.11% of cases were critical, 16.67% were severe, 44.44% were moderate and 27.78% were mild. The main symptoms were fever in 88.89%, dyspnea in 72.22%, and dry cough in 61.11%. The lymphocytic count was normal, decreased, and increased in 44.4%, 33.3%, and 22.2% of cases respectively. The neutrophilic count was increased, normal, and decreased in 55.56%, 27.7%, and 16.6% of cases respectively. TNF-alpha levels were higher in rheumatologic and neurologic groups. CT findings of COVID-19 were detected in 44.44% of cases. Regarding the outcome; 77.8% recovered, 11.11% had complications, and 5.6% died.Conclusion: Although the clinical pattern of COVID-19 among pediatric patients with chronic diseases is more or less similar to adult pattern, laboratory and imaging findings differ, so this may be helpful for early detection of COVID-19 in pediatric patients with chronic disease to avoid unwanted outcomes.
No takes yet. Share an insight, caveat, or question.
Rizk et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: